Truist Financial’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,225
Closed -$266K 2503
2020
Q2
$266K Sell
1,225
-30
-2% -$6.92K ﹤0.01% 2033
2020
Q1
$284K Sell
1,255
-155
-11% -$38.2K ﹤0.01% 1892
2019
Q4
$352K Sell
1,410
-200
-12% -$46.8K ﹤0.01% 2064
2019
Q3
$383K Sell
1,610
-40
-2% -$9.25K 0.01% 616
2019
Q2
$403K Sell
1,650
-100
-6% -$23.3K 0.01% 620
2019
Q1
$403K Sell
1,750
-240
-12% -$54.2K 0.01% 611
2018
Q4
$415K Buy
1,990
+105
+6% +$20.5K 0.01% 577
2018
Q3
$350K Sell
1,885
-90
-5% -$18.1K 0.01% 656
2018
Q2
$417K Sell
1,975
-180
-8% -$31.5K 0.01% 611
2018
Q1
$320K Hold
2,155
0.01% 648
2017
Q4
$268K Sell
2,155
-60
-3% -$8.39K 0.01% 700
2017
Q3
$331K Sell
2,215
-75
-3% -$10.6K 0.01% 657
2017
Q2
$328K Sell
2,290
-370
-14% -$52.6K 0.01% 651
2017
Q1
$326K Sell
2,660
-230
-8% -$28.2K 0.01% 669
2016
Q4
$355K Buy
2,890
+130
+5% +$16.2K 0.01% 655
2016
Q3
$316K Hold
2,760
0.01% 681
2016
Q2
$339K Buy
+2,760
New +$297K 0.01% 661

Other funds holding MLAB

Truist Financial's MLAB Position: Q3 2020 in Review

Truist Financial sold out of Mesa Laboratories (MLAB) in Q3 2020, closing a stake of 1,225 shares — an estimated $266K sold.

Truist Financial first reported a position in MLAB in Q2 2016 and held it in 17 quarters. The position peaked at $417K in Q2 2018. 153 funds tracked by Wall St. Rank hold MLAB as of Q3 2020.

  • Truist Financial reported no remaining Mesa Laboratories position as of Q3 2020 after selling out during the quarter.
  • Truist Financial sold 1,225 Mesa Laboratories shares in Q3 2020, an estimated $266K.
  • Truist Financial first reported a position in Mesa Laboratories in Q2 2016 and held it in 17 quarters.
  • Truist Financial's Mesa Laboratories position peaked at $417K in Q2 2018.
  • 153 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2020.

Based on Truist Financial's 13F filing for Q3 2020, filed 13 Nov 2020.